|
Originally published In Press as doi:10.1074/jbc.M108326200 on April 1, 2002
J. Biol. Chem., Vol. 277, Issue 23, 20256-20263, June 7, 2002
Carboxyl-terminal Peptide of -Amyloid Precursor Protein Blocks
Inositol 1,4,5-Trisphosphate-sensitive Ca2+ Release in
Xenopus laevis Oocytes*
Joung-Hun
Kim §,
Jong-Cheol
Rah¶,
Scott P.
Fraser ,
Keun-A
Chang¶,
Mustafa B. A.
Djamgoz , and
Yoo-Hun
Suh¶
From the Neurobiology Group, Department of Biology,
Sir Alexander Fleming Bldg., Imperial College of Science, Technology
and Medicine, London SW7 2AZ, United Kingdom and the ¶ Department
of Pharmacology, College of Medicine, National Creative Research
Initiative Centre for Alzheimer's Dementia, and Neuroscience
Research Institute, MRC, Seoul National University, Seoul
110-799, South Korea
The effects of Alzheimer's disease-related
amyloidogenic peptides on inositol 1,4,5-trisphosphate
receptor-mediated Ca2+ mobilization were examined in
Xenopus laevis oocytes. Intracellular Ca2+ was
monitored by electrophysiological measurement of the endogenous Ca2+-activated Cl current. Application of a
hyperpolarizing pulse released intracellular Ca2+ in
oocytes primed by pre-injection of a non-metabolizable inositol 1,4,5-trisphosphate analogue. The carboxyl terminus of the amyloid precursor protein inhibited inositol 1,4,5-trisphosphate
receptor-mediated intracellular Ca2+ release in a
dose-dependent manner. Equimolar -amyloid peptides A 1-40 or A 1-42 had no effect, and
whereas a truncated carboxyl terminus lacking the A domain was
equipotent to the full-length one, a carboxyl terminus fragment lacking
the NPTY sequence was less effective than the full-length fragment. The inhibition induced by the carboxyl terminus was not associated with the
block of the Ca2+-dependent Cl
channel itself or compromised Ca2+ influx. We conclude that
the carboxyl terminus of the amyloid precursor protein inhibits
inositol 1,4,5-trisphosphate-sensitive Ca2+ release and
could thus disrupt Ca2+ homeostasis and that the carboxyl
terminus is much more effective than the -amyloid fragments used. By
perturbing the coupling of inositol 1,4,5-trisphosphate and
Ca2+ release, the carboxyl terminus of the amyloid
precursor protein can potentially be involved in inducing the neural
toxicity characteristic of Alzheimer's disease.
*
This work was supported in part by the National Creative
Research Initiative Grant from the Ministry of Science & Technology, the BK21 Human Life Sciences Project, The British
Council (Seoul), Korea, the Rotary Club International, and the Royal
Society (to S. P. F.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: Center for Neurobiology and Behavior, College of
Physicians and Surgeons, Columbia University, 1051 Riverside Dr., New
York, NY 10032.
To whom correspondence should be addressed. Tel.:
82-2-740-8285; Fax: 82-2-745-7996; E-mail:
yhsuh@plaza.snu.ac.kr.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. B. Parekh and J. W. Putney Jr.
Store-Operated Calcium Channels
Physiol Rev,
April 1, 2005;
85(2):
757 - 810.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Suh and F. Checler
Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease
Pharmacol. Rev.,
September 1, 2002;
54(3):
469 - 525.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|